A detailed history of Financial Management Professionals, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Financial Management Professionals, Inc. holds 706 shares of NVO stock, worth $74,172. This represents 0.01% of its overall portfolio holdings.

Number of Shares
706
Previous 1,453 51.41%
Holding current value
$74,172
Previous $207,000 59.42%
% of portfolio
0.01%
Previous 0.03%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$119.07 - $145.42 $88,945 - $108,628
-747 Reduced 51.41%
706 $84,000
Q2 2024

Jul 12, 2024

BUY
$122.71 - $146.91 $91,050 - $109,007
742 Added 104.36%
1,453 $207,000
Q1 2024

Apr 16, 2024

BUY
$102.11 - $135.92 $20,319 - $27,048
199 Added 38.87%
711 $91,000
Q4 2023

Jan 12, 2024

BUY
$87.78 - $105.45 $702 - $843
8 Added 1.59%
512 $53,000
Q3 2023

Oct 13, 2023

BUY
$90.94 - $199.54 $21,007 - $46,093
231 Added 84.62%
504 $46,000
Q2 2023

Jul 10, 2023

SELL
$155.98 - $172.65 $4,367 - $4,834
-28 Reduced 9.3%
273 $44,000
Q1 2023

Apr 13, 2023

BUY
$132.34 - $159.14 $8,602 - $10,344
65 Added 27.54%
301 $48,000
Q4 2022

Jan 11, 2023

SELL
$102.55 - $135.33 $7,793 - $10,285
-76 Reduced 24.36%
236 $32,000
Q3 2022

Oct 27, 2022

BUY
$95.28 - $116.93 $14,482 - $17,773
152 Added 95.0%
312 $31,000
Q2 2022

Jul 12, 2022

BUY
$103.24 - $121.81 $4,852 - $5,725
47 Added 41.59%
160 $18,000
Q1 2022

Apr 27, 2022

SELL
$93.1 - $112.54 $3,537 - $4,276
-38 Reduced 25.17%
113 $13,000
Q4 2021

Jan 28, 2022

BUY
$95.88 - $117.08 $1,821 - $2,224
19 Added 14.39%
151 $17,000
Q3 2021

Nov 02, 2021

BUY
$84.42 - $106.62 $6,162 - $7,783
73 Added 123.73%
132 $13,000
Q1 2021

Apr 26, 2021

BUY
$67.06 - $75.82 $1,609 - $1,819
24 Added 68.57%
59 $4,000
Q4 2020

Feb 03, 2021

BUY
$63.89 - $73.8 $511 - $590
8 Added 29.63%
35 $2,000
Q2 2020

Jul 21, 2020

BUY
$58.54 - $67.94 $1,580 - $1,834
27 New
27 $2,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $237B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Financial Management Professionals, Inc. Portfolio

Follow Financial Management Professionals, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Management Professionals, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Management Professionals, Inc. with notifications on news.